Erratum: Altered Renal Expression of Angiotensin II Receptors, Renin Receptor, and ACE-2 Precede the Development of Renal Fibrosis in Aging Rats (Am J Nephrol (2010) 32 (249-261) DOI: 10.1159/000318607);Altered renal expression of angiotensin ii receptors, renin receptor, and ACE-2 precede the development of renal fibrosis in aging rats

American Journal of Nephrology

Volumn 32, Issue 3, 2010, Pages 249-261

  Schulman, Ivonne Hernandez ^a,b   Zhou, Ming Sheng ^a,b   Treuer, Adriana V ^b   Chadipiralla, Kiranmai ^a   Hare, Joshua M ^b   Raij, Leopoldo ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Angiotensin; Fibrosis; Kidney disease; Nitric oxide; Oxidative stress

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; MANGANESE SUPEROXIDE DISMUTASE; PRORENIN RECEPTOR; RECEPTOR PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; KIDNEY FIBROSIS; MALE; MIDDLE AGED; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 77955120259     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000528782     Document Type: Erratum

References (34)

1. Tan JC, Workeneh B, Busque S, Blouch K, Derby G, Myers BD: Glomerular function, structure, and number in renal allografts from older deceased donors. J Am Soc Nephrol 2009; 20: 181-188.
2. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223-228.
3. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD: The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152: 561-567.
4. Diz DI: Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension 2008; 52: 37-43.
5. De Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, Fraga CG: Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 2003; 17: 1096-1098.
6. Cruz CI, Ruiz-Torres P, del Moral RG, Rodriguez- Puyol M, Rodriguez-Puyol D: Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am J Physiol Renal Physiol 2000; 278:F122-F129.
7. Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario Lores Arnaiz M, Inserra F: Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 2005; 128: 247-252.
8. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
9. Marcussen N: Tubulointerstitial damage leads to atubular glomeruli: significance and possible role in progression. Nephrol Dial Transplant 2000; 15(suppl 6):74-75.
10. August P, Suthanthiran M: Transforming growth factor- and progression of renal disease. Kidney Int Suppl 2003; 87:S99-S104.
11. Ying WZ, Sanders PW: The interrelationship between TGF-1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol 2003; 285:F902-F908.
12. Schulman IH, Raij L: The angiotensin II type 2 receptor: what is its clinical significance? Curr Hypertens Rep 2008; 10: 188-193.
13. Carey RM: Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 2005; 45: 840-844.
14. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W: Renin increases mesangial cell transforming growth factor-1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006; 69: 105-113.
15. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D: Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17: 3067-3075.
16. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM: Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 2008; 74: 1610-1616.
17. Meng Q, Wong YT, Chen J, Ruan R: Age-related changes in mitochondrial function and antioxidative enzyme activity in Fischer 344 rats. Mech Ageing Dev 2007; 128: 286-292.
18. Zhou MS, Schuman IH, Jaimes EA, Raij L: Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol 2008; 295:F53-F59.
19. Schulman IH, Zhou MS, Jaimes EA, Raij L: Dissociation between metabolic and vascular insulin resistance in aging. Am J Physiol 2007; 293:H853-H859.
20. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R: A gp91 phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000; 87: 26-32.
21. Gill PS, Wilcox CS: NADPH oxidases in the kidney. Antioxid Redox Signal 2006; 8: 1597-1607.
22. Schulman IH, Zhou MS, Raij L: Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl 2006; 24: S45-S50.
23. Baylis C: Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 2008; 294:F1-F9.
24. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, Vaziri ND: Association of mitochondrial SOD deficiency with saltsensitive hypertension and accelerated renal senescence. J Appl Physiol 2007; 102: 255-260.
25. Mori T, Cowley AW Jr: Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension 2004; 43: 752-759.
26. Rich AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957; 100: 173-186.
27. Fine LG, Norman JT: Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008; 74: 867-872.
28. Johnson RJ, Gordon KL, Giachelli C, Kurth T, Skelton MM, Cowley AW Jr: Tubulointerstitial injury and loss of nitric oxide synthases parallel the development of hypertension in the Dahl-SS rat. J Hypertens 2000; 18: 1497-1505.
29. Iversen BM, Amann K, Kvam FI, Wang X, Ofstad J: Increased glomerular capillary pressure and size mediate glomerulosclerosis in SHR juxtamedullary cortex. Am J Physiol Renal Physiol 1998; 274:F365-F373.
30. Thompson MM, Oyama TT, Kelly FJ, Kennefick TM, Anderson S: Activity and responsiveness of the renin-angiotensin system in the aging rat. Am J Physiol 2000; 279:R1787-R1794.
31. Sun Y, Zhang J, Zhang JQ, Ramires FJ: Local angiotensin II and transforming growth factor-1 in renal fibrosis of rats. Hypertension 2000; 35: 1078-1084.
32. Zhou XJ, Vaziri ND, Zhang J, Wang HW, Wang XQ: Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT 1 blockade. Kidney Int 2002; 62: 914-921.
33. Nangaku M: Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
34. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP: Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 2009; 20: 1199-1209.